A SNaPshot assay for the rapid and simple detection of four common hotspot codon mutations in the PIK3CA gene

被引:79
作者
Hurst C.D. [1 ]
Zuiverloon T.C. [2 ]
Hafner C. [3 ]
Zwarthoff E.C. [2 ]
Knowles M.A. [1 ]
机构
[1] Cancer Research UK Clinical Centre, Leeds Institute of Molecular Medicine, St James's University Hospital, Leeds
[2] Department of Pathology, Josephine Nefkens Institute, Erasmus MC, Rotterdam
[3] Department of Dermatology, University of Regensburg
关键词
PIK3CA Mutation; High Resolution Melting; H1047R Mutation; High Resolution Melting Analysis; PIK3CA Gene;
D O I
10.1186/1756-0500-2-66
中图分类号
学科分类号
摘要
Background. Activating mutations in the PIK3CA gene have been identified in a variety of human malignancies and are commonly detected in hotspot codons located in the helical and kinase domains in exons 9 and 20. Existing methodologies for the detection of PIK3CA mutations are time-consuming and/or expensive. In the present study we describe the first application of a PIK3CA SNaPshot assay to the screening of frequent mutations in these exons. Findings. A SNaPshot assay for the simultaneous detection of four frequent PIK3CA hotspot mutations (E542K, E545G, E545K and H1047R) has been developed and evaluated. The assay combines multiplex PCR amplification with a multiplex primer extension assay to allow targeted detection of all four mutations in one reaction. The method was tested using samples that had previously been analysed for mutations by high-resolution melting analysis and sequencing. All mutations detected were concordant and no false positive results were obtained. Sensitivity tests showed that the SNaPshot assay could detect mutant DNA when it represents 5-10% of the total DNA present. The application of the method to the analysis of DNAs extracted from formalin-fixed paraffin-embedded samples was also demonstrated. Conclusion. The SNaPshot assay described here offers a fast, sensitive, inexpensive and specific approach to the analysis of frequent PIK3CA mutations in both fresh and archival patient samples. © 2009 Knowles et al.
引用
收藏
相关论文
共 20 条
[1]  
Vivanco I., Sawyers C.L., The phosphatidylinositol 3-Kinase AKT pathway in human cancer, Nat Rev Cancer, 2, pp. 489-501, (2002)
[2]  
Philp A.J., Campbell I.G., Leet C., Vincan E., Rockman S.P., Whitehead R.H., Thomas R.J., Phillips W.A., The phosphatidylinositol 3'-kinase p85alpha gene is an oncogene in human ovarian and colon tumors, Cancer Res, 61, pp. 7426-7429, (2001)
[3]  
Campbell I.G., Russell S.E., Choong D.Y., Montgomery K.G., Ciavarella M.L., Hooi C.S., Cristiano B.E., Pearson R.B., Phillips W.A., Mutation of the PIK3CA gene in ovarian and breast cancer, Cancer Res, 64, pp. 7678-7681, (2004)
[4]  
Hartmann C., Bartels G., Gehlhaar C., Holtkamp N., Von Deimling A., PIK3CA mutations in glioblastoma multiforme, Acta Neuropathol, 109, pp. 639-642, (2005)
[5]  
Lee J.W., Soung Y.H., Kim S.Y., Lee H.W., Park W.S., Nam S.W., Kim S.H., Lee J.Y., Yoo N.J., Lee S.H., PIK3CA gene is frequently mutated in breast carcinomas and hepatocellular carcinomas, Oncogene, 24, pp. 1477-1480, (2005)
[6]  
Levine D.A., Bogomolniy F., Yee C.J., Lash A., Barakat R.R., Borgen P.I., Boyd J., Frequent mutation of the PIK3CA gene in ovarian and breast cancers, Clin Cancer Res, 11, pp. 2875-2878, (2005)
[7]  
Li V.S.W., Wong C.W., Chan T.L., Chan A.S.W., Zhao W., Chu K.-M., So S., Chen X., Yuen S.T., Leung S.Y., Mutations of PIK3CA in gastric adenocarcinoma, BMC Cancer, 5, (2005)
[8]  
Saal L.H., Holm K., Maurer M., Memeo L., Su T., Wang X., Yu J.S., Malmstrom P.O., Mansukhani M., Enoksson J., Et al., PIK3CA mutations correlate with hormone receptors, node metastasis, and ERBB2, and are mutually exclusive with PTEN loss in human breast carcinoma, Cancer Res, 65, pp. 2554-2559, (2005)
[9]  
Wang Y., Helland A., Holm R., Kristensen G.B., Borresen-Dale A.L., PIK3CA mutations in advanced ovarian carcinomas, Hum Mutat, 25, (2005)
[10]  
Wu G., Xing M., Mambo E., Huang X., Liu J., Guo Z., Chatterjee A., Goldenberg D., Gollin S.M., Sukumar S., Et al., Somatic mutation and gain of copy number of PIK3CA in human breast cancer, Breast Cancer Res, 7, pp. 18609-616, (2005)